Physician profile
David Pochatko
NPI 1588646426
$608.90
in general payments reported to CMS, 2019-2025
6 companies · $138 in 2025
The $138 reported for 2025 was less than what a typical Foot and Ankle Surgery provider received nationally (typical 2025 total: $1,200).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13.22 · 2020: $16.48 · 2021: $16.72 · 2022: $13.51 · 2023: $264 · 2024: $147 · 2025: $138.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $549.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $548.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $147.40 | 2024 | Arthrex |
| Prodigy Surgical Distribution, INC. | $143.13 | 2023 | |
| Treace Medical Concepts, INC. | $138.01 | 2025 | |
| Stryker Corporation | $88.97 | 2020-2023 | Asnis, Hydroset, Vitoss |
| Horizon Therapeutics Plc | $78.17 | 2021-2023 | Krystexxa |
| Dynasplint Systems INC. | $13.22 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Pochatko listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.